{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:39:58Z","timestamp":1793489998118,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.tox.2013.08.011","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T17:02:00Z","timestamp":1377277320000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":450,"special_numbering":"C","title":["The adverse outcome pathway concept: A pragmatic tool in toxicology"],"prefix":"10.1016","volume":"312","author":[{"given":"Mathieu","family":"Vinken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2013.08.011_bib0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00204-011-0693-2","article-title":"Alternative (non-animal) methods for cosmetics testing: current status and future prospects\u20142010","volume":"85","author":"Adler","year":"2011","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0010","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1517\/17425255.2011.577740","article-title":"The mechanistic basis for the induction of hepatic steatosis by xenobiotics","volume":"7","author":"Amacher","year":"2011","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0015","first-page":"347","article-title":"Developing in vitro tools sufficient by themselves for 21st century risk assessment","volume":"vol. 2","author":"Andersen","year":"2012"},{"key":"10.1016\/j.tox.2013.08.011_bib0020","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/etc.34","article-title":"Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment","volume":"29","author":"Ankley","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2013.08.011_bib0025","unstructured":"Anon., n.d. http:\/\/caat.jhsph.edu\/ (consulted August 2013)."},{"key":"10.1016\/j.tox.2013.08.011_bib0030","unstructured":"Anon., n.d. http:\/\/www.seurat-1.eu\/ (consulted August 2013)."},{"key":"10.1016\/j.tox.2013.08.011_bib0035","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.tiv.2005.10.012","article-title":"Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol","volume":"20","author":"Ashikaga","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2013.08.011_bib0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","article-title":"Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver","volume":"54","author":"Begriche","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2013.08.011_bib0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/toxsci\/61.1.18","article-title":"Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop","volume":"61","author":"Bogdanffy","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"6037","key":"10.1016\/j.tox.2013.08.011_bib0265","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tox.2013.08.011_bib0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10629360802348985","article-title":"Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach","volume":"19","author":"Enoch","year":"2008","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.tox.2013.08.011_bib0055","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tox.2013.08.011_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tox.2013.08.011_bib0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfm064","article-title":"Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach","volume":"97","author":"Gerberick","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2013.08.011_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/026119290803600210","article-title":"Chemical reactivity measurement and the predictive identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64","volume":"36","author":"Gerberick","year":"2008","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.tox.2013.08.011_bib0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/026119290403200505","article-title":"Development and prevalidation of a list of structure\u2013activity relationship rules to be used in expert systems for prediction of the skin-sensitising properties of chemicals","volume":"32","author":"Gerner","year":"2004","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.tox.2013.08.011_bib0080","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.tox.2013.08.011_bib0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp060004w","article-title":"High-speed screening and QSAR analysis of human ATP-binding cassette transporter ABCB11 (bile salt export pump) to predict drug-induced intrahepatic cholestasis","volume":"2","author":"Hirano","year":"2006","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tox.2013.08.011_bib0090","series-title":"The Liver: Biology and Pathobiology","first-page":"289","article-title":"Bile acids and the enterohepatic circulation","author":"Hofmann","year":"2009"},{"key":"10.1016\/j.tox.2013.08.011_bib0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/1874104500802010087","article-title":"Two- and three-dimensional quantitative structure\u2013activity relationships studies on a series of liver x receptor ligands","volume":"2","author":"Honorio","year":"2008","journal-title":"Open Med. Chem. J."},{"key":"10.1016\/j.tox.2013.08.011_bib0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.14573\/altex.2013.1.051","article-title":"Perspectives on validation of high-throughput assays supporting 21st century toxicity testing","volume":"30","author":"Judson","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2013.08.011_bib0105","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1080\/10408390903110692","article-title":"The key events dose\u2013response framework: a cross-disciplinary mode-of-action based approach to examining dose\u2013response and thresholds","volume":"49","author":"Julien","year":"2009","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.tox.2013.08.011_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/10937404.2010.483935","article-title":"Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk","volume":"13","author":"Kavlock","year":"2010","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.tox.2013.08.011_bib0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/toxsci\/59.2.198","article-title":"Skin sensitization testing in potency and risk assessment","volume":"59","author":"Kimber","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2013.08.011_bib0120","series-title":"JRC Scientific and Policy Report 75689","article-title":"Description of prototype modes-of-action related to repeated dose toxicity","author":"Landesmann","year":"2012"},{"key":"10.1016\/j.tox.2013.08.011_bib0125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.tox.2013.08.011_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.14573\/altex.2011.1.050","article-title":"Skin sensitisation: the Colipa strategy for developing and evaluating non-animal test methods for risk assessment","volume":"28","author":"Maxwell","year":"2011","journal-title":"ALTEX"},{"key":"10.1016\/j.tox.2013.08.011_bib0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0140","series-title":"Toxicity Testing in the 21st Century: A Vision and a Strategy","author":"NRC","year":"2007"},{"key":"10.1016\/j.tox.2013.08.011_bib0145","series-title":"Proposal for a template and guidance on developing and assessing the completeness of adverse outcome pathways","author":"OECD","year":"2012"},{"key":"10.1016\/j.tox.2013.08.011_bib0150","article-title":"The adverse outcome pathway for skin sensitization initiated by covalent binding to proteins. Part I: Scientific evidence","author":"OECD","year":"2012"},{"key":"10.1016\/j.tox.2013.08.011_bib0155","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2013.08.011_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.taap.2006.12.026","article-title":"Assessment of the U937 cell line for the detection of contact allergens","volume":"220","author":"Python","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2013.08.011_bib0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in drug-induced liver disease","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tox.2013.08.011_bib0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jat.1293","article-title":"Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential","volume":"28","author":"Roberts","year":"2008","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1208\/s12248-009-9137-9","article-title":"Technical pitfalls and improvements for high-speed screening and QSAR analysis to predict inhibitors of the human bile salt export pump (ABCB11\/BSEP)","volume":"11","author":"Saito","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.tox.2013.08.011_bib0180","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.tiv.2005.10.014","article-title":"Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT","volume":"20","author":"Sakaguchi","year":"2006","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2013.08.011_bib0185","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"Schoemaker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2013.08.011_bib0190","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10408440591007133","article-title":"Overview: using mode of action and life stage information to evaluate the human relevance of animal toxicity data","volume":"35","author":"Seed","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0195","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.tox.2006.04.032","article-title":"Use of computer-assisted prediction of toxic effects of chemical substances","volume":"224","author":"Simon-Hettich","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2013.08.011_bib0200","series-title":"Guidelines for carcinogen risk assessment","author":"US EPA","year":"2005"},{"key":"10.1016\/j.tox.2013.08.011_bib0205","doi-asserted-by":"crossref","DOI":"10.1111\/cod.12117","article-title":"Categorization of fragrance contact allergens for prioritization of preventive measures: clinical and experimental data and consideration of structure\u2013activity relationships","author":"Uter","year":"2013","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.tox.2013.08.011_bib0210","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00204-011-0769-z","article-title":"Screening of repeated dose toxicity data present in SCC(NF)P\/SCCS safety evaluations of cosmetic ingredients","volume":"86","author":"Vinken","year":"2012","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0215","doi-asserted-by":"crossref","DOI":"10.1093\/toxsci\/kft177","article-title":"Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury","author":"Vinken","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2013.08.011_bib0220","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1398-9995.2009.02082.x","article-title":"Effector and regulatory mechanisms in allergic contact dermatitis","volume":"64","author":"Vocanson","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.tox.2013.08.011_bib0225","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tox.2013.08.011_bib0230","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1124\/dmd.112.047068","article-title":"Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification","volume":"40","author":"Warner","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2013.08.011_bib0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/etc.373","article-title":"Defining and modeling known adverse outcome pathways: domoic acid and neuronal signaling as a case study","volume":"30","author":"Watanabe","year":"2011","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.tox.2013.08.011_bib0240","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tox.2013.08.011_bib0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.aquatox.2012.09.008","article-title":"Adverse outcome pathways during zebrafish embryogenesis: a case study with paraoxon","volume":"126","author":"Yozzo","year":"2013","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.tox.2013.08.011_bib0250","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1089-3261(05)70097-0","article-title":"Drug-induced liver disease","volume":"4","author":"Zimmerman","year":"2000","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.tox.2013.08.011_bib0255","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s10354-006-0312-7","article-title":"Molecular mechanisms of cholestasis","volume":"156","author":"Zollner","year":"2006","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.tox.2013.08.011_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin. Liver Dis."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X13002308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X13002308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:26:35Z","timestamp":1759533995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X13002308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":53,"alternative-id":["S0300483X13002308"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2013.08.011","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adverse outcome pathway concept: A pragmatic tool in toxicology","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2013.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}